Literature DB >> 10523637

Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.

A Javed1, S Gutierrez, M Montecino, A J van Wijnen, J L Stein, G S Stein, J B Lian.   

Abstract

Three Cbfa motifs are strategically positioned in the bone-specific rat osteocalcin (rOC) promoter. Sites A and B flank the vitamin D response element in the distal promoter and sites B and C flank a positioned nucleosome in the proximal promoter. The functional significance of each Cbfa element was addressed by mutating individual or multiple Cbfa sites within the context of the -1.1-kb rOC promoter fused to a chloramphenicol acetyltransferase reporter gene. Promoter activity was assayed following transient transfection and after stable genomic integration in ROS 17/2.8 osteoblastic cell lines. We show that all three Cbfa sites are required for maximal basal expression of the rOC promoter. However, the distal sites A and B each contribute significantly more (P < 0.001) to promoter activity than site C. In a genomic context, sites A and B can largely compensate for a mutation at the proximal site C, and paired mutations involving site A (mAB or mAC) result in a far greater loss of activity than the mBC mutation. Strikingly, mutation of the three Cbfa sites leads to abrogation of responsiveness to vitamin D. Vitamin D-enhanced activity is also not observed when sites A and B are mutated. Significantly, related to these losses in transcriptional activity, mutation of the three Cbfa sites results in altered chromatin structure as reflected by loss of DNase I-hypersensitive sites at the vitamin D response element and over the proximal tissue-specific basal promoter. These findings strongly support a multifunctional role for Cbfa factors in regulating gene expression, not only as simple transcriptional transactivators but also by facilitating modifications in promoter architecture and chromatin organization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523637      PMCID: PMC84749          DOI: 10.1128/MCB.19.11.7491

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription.

Authors:  S W Hiebert; W Sun; J N Davis; T Golub; S Shurtleff; A Buijs; J R Downing; G Grosveld; M F Roussell; D G Gilliland; N Lenny; S Meyers
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family.

Authors:  M Y Ahn; S C Bae; M Maruyama; Y Ito
Journal:  Gene       Date:  1996-02-12       Impact factor: 3.688

Review 3.  Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones.

Authors:  J B Lian; G S Stein; J L Stein; A J van Wijnen
Journal:  Vitam Horm       Date:  1999       Impact factor: 3.421

Review 4.  Chromatin structure of the MMTV promoter and its changes during hormonal induction.

Authors:  M Truss; J Bartsch; C Möws; S Chávez; M Beato
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

5.  AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.

Authors:  S Meyers; N Lenny; W Sun; S W Hiebert
Journal:  Oncogene       Date:  1996-07-18       Impact factor: 9.867

6.  Changes in chromatin structure support constitutive and developmentally regulated transcription of the bone-specific osteocalcin gene in osteoblastic cells.

Authors:  M Montecino; J Lian; G Stein; J Stein
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

7.  Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.

Authors:  T L Clemens; H Tang; S Maeda; R A Kesterson; F Demayo; J W Pike; C M Gundberg
Journal:  J Bone Miner Res       Date:  1997-10       Impact factor: 6.741

8.  An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene.

Authors:  C Banerjee; S W Hiebert; J L Stein; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain.

Authors:  B Frenkel; M Montecino; J Green; F Aslam; R Desai; C Banerjee; J L Stein; J B Lian; G S Stein
Journal:  Endocrinology       Date:  1996-03       Impact factor: 4.736

10.  Transforming growth factor-beta 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site.

Authors:  C Banerjee; J L Stein; A J Van Wijnen; B Frenkel; J B Lian; G S Stein
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  47 in total

1.  In vivo analysis of a developmental circuit for direct transcriptional activation and repression in the same cell by a Runx protein.

Authors:  Jude Canon; Utpal Banerjee
Journal:  Genes Dev       Date:  2003-04-01       Impact factor: 11.361

2.  Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells.

Authors:  Sayyed K Zaidi; Daniel W Young; Shirwin M Pockwinse; Amjad Javed; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.

Authors:  Sayyed K Zaidi; Andrew J Sullivan; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation.

Authors:  Sunhwa Kim; Takako Koga; Miho Isobe; Britt E Kern; Taeko Yokochi; Y Eugene Chin; Gerard Karsenty; Tadatsugu Taniguchi; Hiroshi Takayanagi
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

5.  Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.

Authors:  Gauthami Jalagadugula; Guangfen Mao; Gurpreet Kaur; Lawrence E Goldfinger; Danny N Dhanasekaran; A Koneti Rao
Journal:  Blood       Date:  2010-09-27       Impact factor: 22.113

Review 6.  Organization of transcriptional regulatory machinery in nuclear microenvironments: implications for biological control and cancer.

Authors:  Gary S Stein; Jane B Lian; Andre J van Wijnen; Janet L Stein; Amjad Javed; Martin Montecino; Je-Yong Choi; Diana Vradii; Sayyed K Zaidi; Jitesh Pratap; Daniel Young
Journal:  Adv Enzyme Regul       Date:  2007-03-23

Review 7.  Transcription-factor-mediated epigenetic control of cell fate and lineage commitment.

Authors:  Gary S Stein; Sayyed K Zaidi; Janet L Stein; Jane B Lian; Andre J van Wijnen; Martin Montecino; Daniel W Young; Amjad Javed; Jitesh Pratap; Je-Yong Choi; Syed A Ali; Sandhya Pande; Mohammad Q Hassan
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

8.  Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.

Authors:  Eric D Jensen; Tania M Schroeder; Jaclyn Bailey; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

9.  Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells.

Authors:  Changhui Deng; Eric Ueda; Kuanhui E Chen; Craig Bula; Anthony W Norman; Richard A Luben; Ameae M Walker
Journal:  Mol Endocrinol       Date:  2008-12-12

10.  Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization.

Authors:  Robert F Klees; Roman M Salasznyk; Donald F Ward; Donna E Crone; William A Williams; Mark P Harris; Adele Boskey; Vito Quaranta; George E Plopper
Journal:  Exp Cell Res       Date:  2008-01-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.